Bibliography
- Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High BP. The JNC 7 Report. JAMA 2003; 289: 2560–2572.
- Guidelines Committee, 2003 European Society of Hypertension. European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 2003;21: 1011–1053.
- National Institute for Health and Clinical Excellence. NICE clinical guideline 34. Hypertension 2006.
- Choice of Therapy in Essential Hypertension. UptoDate. 2007. http://www.uptodate.com
- British Hypertension Society BHS Guidelines. Guidelines for Management of Hypertension. Report of the 3rd working party. J Hypertens 1999; 13: 569–592.
References
- Southern African Hypertension Guideline 2006. S Afr Med J 2006 April; 96: 335–362
- Dahlof B, Sever PS, Poulter NR, et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazode as required, in the Anglo-Scandinavian Cardiac outcomes Trial-BP Lowering Arm (ASCOT-BPLA): a multicentre randomized controlled trial. Lancet 2005; 366: 895–906
- Materson BJ, Reda DJ, Cushman WC, et al. N Engl J Med. 1993; 328: 914. Correction and additional data: Am J Hypertens 1995; 8: 189.
- Dahlof B, Devereux R, De Faire U, et al. The Losartan Intervention for Endpoint reduction (LIFE) in hypertension study: rationale, design, and methods. The LIFE Study Group. Am J Hypertens 1997; 10: 705–713.
- Epstein M, Bakris G. Arch Intern Med 1996; 156: 1969. Redrawn.